Global Myotonic Dystrophy Type 1 (DM1) Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Myotonic Dystrophy Type 1 (DM1) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Myotonic Dystrophy Type 1 (DM1) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Myotonic Dystrophy Type 1 (DM1) market in any manner.
Global Myotonic Dystrophy Type 1 (DM1) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Dyne
Audentes
Pfizer
Vertex
PepGen
NeuBase Therapeutics
Lupin
AMO Pharma
Expansion Therapeutics
Harmony Biosciences
Market Segmentation (by Type)
Exondys
Emflaza
Translarna
Market Segmentation (by Application)
Hospitals
Clinics
Home Care
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Myotonic Dystrophy Type 1 (DM1) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Myotonic Dystrophy Type 1 (DM1) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Myotonic Dystrophy Type 1 (DM1) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Myotonic Dystrophy Type 1 (DM1) market in any manner.
Global Myotonic Dystrophy Type 1 (DM1) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Dyne
Audentes
Pfizer
Vertex
PepGen
NeuBase Therapeutics
Lupin
AMO Pharma
Expansion Therapeutics
Harmony Biosciences
Market Segmentation (by Type)
Exondys
Emflaza
Translarna
Market Segmentation (by Application)
Hospitals
Clinics
Home Care
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Myotonic Dystrophy Type 1 (DM1) Market
- Overview of the regional outlook of the Myotonic Dystrophy Type 1 (DM1) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Myotonic Dystrophy Type 1 (DM1) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Myotonic Dystrophy Type 1 (DM1)
1.2 Key Market Segments
1.2.1 Myotonic Dystrophy Type 1 (DM1) Segment by Type
1.2.2 Myotonic Dystrophy Type 1 (DM1) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Myotonic Dystrophy Type 1 (DM1) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET COMPETITIVE LANDSCAPE
3.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Manufacturers (2019-2024)
3.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Manufacturers (2019-2024)
3.3 Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Myotonic Dystrophy Type 1 (DM1) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Myotonic Dystrophy Type 1 (DM1) Sales Sites, Area Served, Product Type
3.6 Myotonic Dystrophy Type 1 (DM1) Market Competitive Situation and Trends
3.6.1 Myotonic Dystrophy Type 1 (DM1) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Myotonic Dystrophy Type 1 (DM1) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MYOTONIC DYSTROPHY TYPE 1 (DM1) INDUSTRY CHAIN ANALYSIS
4.1 Myotonic Dystrophy Type 1 (DM1) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2019-2024)
6.3 Global Myotonic Dystrophy Type 1 (DM1) Market Size Market Share by Type (2019-2024)
6.4 Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2019-2024)
7 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Myotonic Dystrophy Type 1 (DM1) Market Sales by Application (2019-2024)
7.3 Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) by Application (2019-2024)
7.4 Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate by Application (2019-2024)
8 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET SEGMENTATION BY REGION
8.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Region
8.1.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Region
8.1.2 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region
8.2 North America
8.2.1 North America Myotonic Dystrophy Type 1 (DM1) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Myotonic Dystrophy Type 1 (DM1) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Dyne
9.1.1 Dyne Myotonic Dystrophy Type 1 (DM1) Basic Information
9.1.2 Dyne Myotonic Dystrophy Type 1 (DM1) Product Overview
9.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.1.4 Dyne Business Overview
9.1.5 Dyne Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
9.1.6 Dyne Recent Developments
9.2 Audentes
9.2.1 Audentes Myotonic Dystrophy Type 1 (DM1) Basic Information
9.2.2 Audentes Myotonic Dystrophy Type 1 (DM1) Product Overview
9.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.2.4 Audentes Business Overview
9.2.5 Audentes Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
9.2.6 Audentes Recent Developments
9.3 Pfizer
9.3.1 Pfizer Myotonic Dystrophy Type 1 (DM1) Basic Information
9.3.2 Pfizer Myotonic Dystrophy Type 1 (DM1) Product Overview
9.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.3.4 Pfizer Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Vertex
9.4.1 Vertex Myotonic Dystrophy Type 1 (DM1) Basic Information
9.4.2 Vertex Myotonic Dystrophy Type 1 (DM1) Product Overview
9.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.4.4 Vertex Business Overview
9.4.5 Vertex Recent Developments
9.5 PepGen
9.5.1 PepGen Myotonic Dystrophy Type 1 (DM1) Basic Information
9.5.2 PepGen Myotonic Dystrophy Type 1 (DM1) Product Overview
9.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.5.4 PepGen Business Overview
9.5.5 PepGen Recent Developments
9.6 NeuBase Therapeutics
9.6.1 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Basic Information
9.6.2 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Overview
9.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.6.4 NeuBase Therapeutics Business Overview
9.6.5 NeuBase Therapeutics Recent Developments
9.7 Lupin
9.7.1 Lupin Myotonic Dystrophy Type 1 (DM1) Basic Information
9.7.2 Lupin Myotonic Dystrophy Type 1 (DM1) Product Overview
9.7.3 Lupin Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.7.4 Lupin Business Overview
9.7.5 Lupin Recent Developments
9.8 AMO Pharma
9.8.1 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Basic Information
9.8.2 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Overview
9.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.8.4 AMO Pharma Business Overview
9.8.5 AMO Pharma Recent Developments
9.9 Expansion Therapeutics
9.9.1 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Basic Information
9.9.2 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Overview
9.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.9.4 Expansion Therapeutics Business Overview
9.9.5 Expansion Therapeutics Recent Developments
9.10 Harmony Biosciences
9.10.1 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Basic Information
9.10.2 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Overview
9.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.10.4 Harmony Biosciences Business Overview
9.10.5 Harmony Biosciences Recent Developments
10 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET FORECAST BY REGION
10.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast
10.2 Global Myotonic Dystrophy Type 1 (DM1) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country
10.2.3 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Region
10.2.4 South America Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Myotonic Dystrophy Type 1 (DM1) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Myotonic Dystrophy Type 1 (DM1) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Myotonic Dystrophy Type 1 (DM1) by Type (2025-2030)
11.1.2 Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Myotonic Dystrophy Type 1 (DM1) by Type (2025-2030)
11.2 Global Myotonic Dystrophy Type 1 (DM1) Market Forecast by Application (2025-2030)
11.2.1 Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) Forecast by Application
11.2.2 Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Myotonic Dystrophy Type 1 (DM1)
1.2 Key Market Segments
1.2.1 Myotonic Dystrophy Type 1 (DM1) Segment by Type
1.2.2 Myotonic Dystrophy Type 1 (DM1) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Myotonic Dystrophy Type 1 (DM1) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET COMPETITIVE LANDSCAPE
3.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Manufacturers (2019-2024)
3.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Manufacturers (2019-2024)
3.3 Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Myotonic Dystrophy Type 1 (DM1) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Myotonic Dystrophy Type 1 (DM1) Sales Sites, Area Served, Product Type
3.6 Myotonic Dystrophy Type 1 (DM1) Market Competitive Situation and Trends
3.6.1 Myotonic Dystrophy Type 1 (DM1) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Myotonic Dystrophy Type 1 (DM1) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MYOTONIC DYSTROPHY TYPE 1 (DM1) INDUSTRY CHAIN ANALYSIS
4.1 Myotonic Dystrophy Type 1 (DM1) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2019-2024)
6.3 Global Myotonic Dystrophy Type 1 (DM1) Market Size Market Share by Type (2019-2024)
6.4 Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2019-2024)
7 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Myotonic Dystrophy Type 1 (DM1) Market Sales by Application (2019-2024)
7.3 Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) by Application (2019-2024)
7.4 Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate by Application (2019-2024)
8 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET SEGMENTATION BY REGION
8.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Region
8.1.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Region
8.1.2 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region
8.2 North America
8.2.1 North America Myotonic Dystrophy Type 1 (DM1) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Myotonic Dystrophy Type 1 (DM1) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Dyne
9.1.1 Dyne Myotonic Dystrophy Type 1 (DM1) Basic Information
9.1.2 Dyne Myotonic Dystrophy Type 1 (DM1) Product Overview
9.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.1.4 Dyne Business Overview
9.1.5 Dyne Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
9.1.6 Dyne Recent Developments
9.2 Audentes
9.2.1 Audentes Myotonic Dystrophy Type 1 (DM1) Basic Information
9.2.2 Audentes Myotonic Dystrophy Type 1 (DM1) Product Overview
9.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.2.4 Audentes Business Overview
9.2.5 Audentes Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
9.2.6 Audentes Recent Developments
9.3 Pfizer
9.3.1 Pfizer Myotonic Dystrophy Type 1 (DM1) Basic Information
9.3.2 Pfizer Myotonic Dystrophy Type 1 (DM1) Product Overview
9.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.3.4 Pfizer Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Vertex
9.4.1 Vertex Myotonic Dystrophy Type 1 (DM1) Basic Information
9.4.2 Vertex Myotonic Dystrophy Type 1 (DM1) Product Overview
9.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.4.4 Vertex Business Overview
9.4.5 Vertex Recent Developments
9.5 PepGen
9.5.1 PepGen Myotonic Dystrophy Type 1 (DM1) Basic Information
9.5.2 PepGen Myotonic Dystrophy Type 1 (DM1) Product Overview
9.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.5.4 PepGen Business Overview
9.5.5 PepGen Recent Developments
9.6 NeuBase Therapeutics
9.6.1 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Basic Information
9.6.2 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Overview
9.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.6.4 NeuBase Therapeutics Business Overview
9.6.5 NeuBase Therapeutics Recent Developments
9.7 Lupin
9.7.1 Lupin Myotonic Dystrophy Type 1 (DM1) Basic Information
9.7.2 Lupin Myotonic Dystrophy Type 1 (DM1) Product Overview
9.7.3 Lupin Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.7.4 Lupin Business Overview
9.7.5 Lupin Recent Developments
9.8 AMO Pharma
9.8.1 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Basic Information
9.8.2 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Overview
9.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.8.4 AMO Pharma Business Overview
9.8.5 AMO Pharma Recent Developments
9.9 Expansion Therapeutics
9.9.1 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Basic Information
9.9.2 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Overview
9.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.9.4 Expansion Therapeutics Business Overview
9.9.5 Expansion Therapeutics Recent Developments
9.10 Harmony Biosciences
9.10.1 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Basic Information
9.10.2 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Overview
9.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Market Performance
9.10.4 Harmony Biosciences Business Overview
9.10.5 Harmony Biosciences Recent Developments
10 MYOTONIC DYSTROPHY TYPE 1 (DM1) MARKET FORECAST BY REGION
10.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast
10.2 Global Myotonic Dystrophy Type 1 (DM1) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country
10.2.3 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Region
10.2.4 South America Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Myotonic Dystrophy Type 1 (DM1) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Myotonic Dystrophy Type 1 (DM1) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Myotonic Dystrophy Type 1 (DM1) by Type (2025-2030)
11.1.2 Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Myotonic Dystrophy Type 1 (DM1) by Type (2025-2030)
11.2 Global Myotonic Dystrophy Type 1 (DM1) Market Forecast by Application (2025-2030)
11.2.1 Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) Forecast by Application
11.2.2 Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Myotonic Dystrophy Type 1 (DM1) Market Size Comparison by Region (M USD)
Table 5. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Myotonic Dystrophy Type 1 (DM1) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myotonic Dystrophy Type 1 (DM1) as of 2022)
Table 10. Global Market Myotonic Dystrophy Type 1 (DM1) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Myotonic Dystrophy Type 1 (DM1) Sales Sites and Area Served
Table 12. Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
Table 13. Global Myotonic Dystrophy Type 1 (DM1) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Myotonic Dystrophy Type 1 (DM1)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Myotonic Dystrophy Type 1 (DM1) Market Challenges
Table 22. Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (Kilotons)
Table 23. Global Myotonic Dystrophy Type 1 (DM1) Market Size by Type (M USD)
Table 24. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2019-2024)
Table 26. Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) by Type (2019-2024)
Table 27. Global Myotonic Dystrophy Type 1 (DM1) Market Size Share by Type (2019-2024)
Table 28. Global Myotonic Dystrophy Type 1 (DM1) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) by Application
Table 30. Global Myotonic Dystrophy Type 1 (DM1) Market Size by Application
Table 31. Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2019-2024)
Table 33. Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2019-2024) & (M USD)
Table 34. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application (2019-2024)
Table 35. Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate by Application (2019-2024)
Table 36. Global Myotonic Dystrophy Type 1 (DM1) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2019-2024)
Table 38. North America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales by Region (2019-2024) & (Kilotons)
Table 43. Dyne Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 44. Dyne Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 45. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Dyne Business Overview
Table 47. Dyne Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
Table 48. Dyne Recent Developments
Table 49. Audentes Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 50. Audentes Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 51. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Audentes Business Overview
Table 53. Audentes Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
Table 54. Audentes Recent Developments
Table 55. Pfizer Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 56. Pfizer Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 57. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Vertex Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 62. Vertex Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 63. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Vertex Business Overview
Table 65. Vertex Recent Developments
Table 66. PepGen Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 67. PepGen Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 68. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. PepGen Business Overview
Table 70. PepGen Recent Developments
Table 71. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 72. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 73. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. NeuBase Therapeutics Business Overview
Table 75. NeuBase Therapeutics Recent Developments
Table 76. Lupin Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 77. Lupin Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 78. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Lupin Business Overview
Table 80. Lupin Recent Developments
Table 81. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 82. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 83. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. AMO Pharma Business Overview
Table 85. AMO Pharma Recent Developments
Table 86. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 87. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 88. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Expansion Therapeutics Business Overview
Table 90. Expansion Therapeutics Recent Developments
Table 91. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 92. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 93. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Harmony Biosciences Business Overview
Table 95. Harmony Biosciences Recent Developments
Table 96. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Myotonic Dystrophy Type 1 (DM1) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Myotonic Dystrophy Type 1 (DM1) Market Size Comparison by Region (M USD)
Table 5. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Myotonic Dystrophy Type 1 (DM1) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myotonic Dystrophy Type 1 (DM1) as of 2022)
Table 10. Global Market Myotonic Dystrophy Type 1 (DM1) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Myotonic Dystrophy Type 1 (DM1) Sales Sites and Area Served
Table 12. Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
Table 13. Global Myotonic Dystrophy Type 1 (DM1) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Myotonic Dystrophy Type 1 (DM1)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Myotonic Dystrophy Type 1 (DM1) Market Challenges
Table 22. Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (Kilotons)
Table 23. Global Myotonic Dystrophy Type 1 (DM1) Market Size by Type (M USD)
Table 24. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2019-2024)
Table 26. Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) by Type (2019-2024)
Table 27. Global Myotonic Dystrophy Type 1 (DM1) Market Size Share by Type (2019-2024)
Table 28. Global Myotonic Dystrophy Type 1 (DM1) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) by Application
Table 30. Global Myotonic Dystrophy Type 1 (DM1) Market Size by Application
Table 31. Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2019-2024)
Table 33. Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2019-2024) & (M USD)
Table 34. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application (2019-2024)
Table 35. Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate by Application (2019-2024)
Table 36. Global Myotonic Dystrophy Type 1 (DM1) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2019-2024)
Table 38. North America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales by Region (2019-2024) & (Kilotons)
Table 43. Dyne Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 44. Dyne Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 45. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Dyne Business Overview
Table 47. Dyne Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
Table 48. Dyne Recent Developments
Table 49. Audentes Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 50. Audentes Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 51. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Audentes Business Overview
Table 53. Audentes Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
Table 54. Audentes Recent Developments
Table 55. Pfizer Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 56. Pfizer Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 57. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Myotonic Dystrophy Type 1 (DM1) SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Vertex Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 62. Vertex Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 63. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Vertex Business Overview
Table 65. Vertex Recent Developments
Table 66. PepGen Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 67. PepGen Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 68. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. PepGen Business Overview
Table 70. PepGen Recent Developments
Table 71. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 72. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 73. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. NeuBase Therapeutics Business Overview
Table 75. NeuBase Therapeutics Recent Developments
Table 76. Lupin Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 77. Lupin Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 78. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Lupin Business Overview
Table 80. Lupin Recent Developments
Table 81. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 82. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 83. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. AMO Pharma Business Overview
Table 85. AMO Pharma Recent Developments
Table 86. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 87. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 88. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Expansion Therapeutics Business Overview
Table 90. Expansion Therapeutics Recent Developments
Table 91. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Basic Information
Table 92. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Overview
Table 93. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Harmony Biosciences Business Overview
Table 95. Harmony Biosciences Recent Developments
Table 96. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Myotonic Dystrophy Type 1 (DM1) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Myotonic Dystrophy Type 1 (DM1)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD), 2019-2030
Figure 5. Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) (2019-2030)
Figure 6. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Myotonic Dystrophy Type 1 (DM1) Market Size by Country (M USD)
Figure 11. Myotonic Dystrophy Type 1 (DM1) Sales Share by Manufacturers in 2023
Figure 12. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Manufacturers in 2023
Figure 13. Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Myotonic Dystrophy Type 1 (DM1) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Myotonic Dystrophy Type 1 (DM1) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Type
Figure 18. Sales Market Share of Myotonic Dystrophy Type 1 (DM1) by Type (2019-2024)
Figure 19. Sales Market Share of Myotonic Dystrophy Type 1 (DM1) by Type in 2023
Figure 20. Market Size Share of Myotonic Dystrophy Type 1 (DM1) by Type (2019-2024)
Figure 21. Market Size Market Share of Myotonic Dystrophy Type 1 (DM1) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application
Figure 24. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2019-2024)
Figure 25. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application in 2023
Figure 26. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application (2019-2024)
Figure 27. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application in 2023
Figure 28. Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2019-2024)
Figure 30. North America Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2023
Figure 32. U.S. Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Myotonic Dystrophy Type 1 (DM1) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2023
Figure 37. Germany Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region in 2023
Figure 44. China Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (Kilotons)
Figure 50. South America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2023
Figure 51. Brazil Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Myotonic Dystrophy Type 1 (DM1) Market Share Forecast by Type (2025-2030)
Figure 65. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Application (2025-2030)
Figure 66. Global Myotonic Dystrophy Type 1 (DM1) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Myotonic Dystrophy Type 1 (DM1)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD), 2019-2030
Figure 5. Global Myotonic Dystrophy Type 1 (DM1) Market Size (M USD) (2019-2030)
Figure 6. Global Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Myotonic Dystrophy Type 1 (DM1) Market Size by Country (M USD)
Figure 11. Myotonic Dystrophy Type 1 (DM1) Sales Share by Manufacturers in 2023
Figure 12. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Manufacturers in 2023
Figure 13. Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Myotonic Dystrophy Type 1 (DM1) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Myotonic Dystrophy Type 1 (DM1) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Type
Figure 18. Sales Market Share of Myotonic Dystrophy Type 1 (DM1) by Type (2019-2024)
Figure 19. Sales Market Share of Myotonic Dystrophy Type 1 (DM1) by Type in 2023
Figure 20. Market Size Share of Myotonic Dystrophy Type 1 (DM1) by Type (2019-2024)
Figure 21. Market Size Market Share of Myotonic Dystrophy Type 1 (DM1) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application
Figure 24. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2019-2024)
Figure 25. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application in 2023
Figure 26. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application (2019-2024)
Figure 27. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application in 2023
Figure 28. Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2019-2024)
Figure 30. North America Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2023
Figure 32. U.S. Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Myotonic Dystrophy Type 1 (DM1) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Myotonic Dystrophy Type 1 (DM1) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2023
Figure 37. Germany Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region in 2023
Figure 44. China Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (Kilotons)
Figure 50. South America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country in 2023
Figure 51. Brazil Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Myotonic Dystrophy Type 1 (DM1) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Myotonic Dystrophy Type 1 (DM1) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Myotonic Dystrophy Type 1 (DM1) Market Share Forecast by Type (2025-2030)
Figure 65. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Application (2025-2030)
Figure 66. Global Myotonic Dystrophy Type 1 (DM1) Market Share Forecast by Application (2025-2030)
